Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects

被引:0
|
作者
Nicholas, TW
Read, SB
Burrows, FJ
Kruse, CA
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Immunol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA
[3] Chiron Technol Ctr Gene Therapy, San Diego, CA USA
关键词
glioma; connexin; gap junctions; suicide gene therapy; bystander effect;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Connexins are proteins that form gap junctions between cells in various mammalian tissues. Because of their role in intercellular communication, connexins are important in the bystander cell death seen in Herpes simplex virus-thymidine kinase (HSV-TK) gene therapy for brain tumors. A selective review of connexin transduction/transfection studies with particular emphasis to central nervous system tumor cells is presented. In addition, specific references to studies with cell types that demonstrate low gap junction intercellular communication are presented. Data are included with the HT-29 colorectal tumor cell line to support the concept that enhancing gap junction protein expression in otherwise low gap junction communicating HT-29 cells increases bystander cell death and reduces tumor burden beyond what might be expected from HSV-TK and ganciclovir (GCV) treatment alone. Maximum in vitro bystander cell death was always produced when GCV treated co-cultures of TK-transduced and non-TK-transduced HT-29 cell lines were also transduced with connexin-43. When connexin was present in only one group of cells in the co-culture, there was more bystander cell death observed with connexin transduced into the non- TK-transduced cells, rather than the TK-transduced cells. The data presented reinforces conclusions made from earlier findings from cell line mixing experiments in which the non-TK-transduced cell population determined the level of bystander cell death (Burrows et al., 2002).
引用
收藏
页码:495 / 507
页数:13
相关论文
共 50 条
  • [21] Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir
    Haberkorn, U
    Altmann, A
    Morr, I
    Germann, C
    Oberdorfer, F
    vanKaick, G
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (07) : 1048 - 1054
  • [22] Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma
    Nikolai G Rainov
    Carsten Fels
    Jan Wilhelm Dröege
    Christoph Schäfer
    Christof M Kramm
    Ting-Chao Chou
    Cancer Gene Therapy, 2001, 8 : 662 - 668
  • [23] Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma
    Rainov, NG
    Fels, C
    Dröge, JW
    Schäfer, C
    Kramm, CM
    Chou, TC
    CANCER GENE THERAPY, 2001, 8 (09) : 662 - 668
  • [24] Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant
    Qiao, J
    Black, ME
    Caruso, M
    HUMAN GENE THERAPY, 2000, 11 (11) : 1569 - 1576
  • [25] Bystander effect-mediated gene therapy of gliomas using herpes simplex virus thymidine kinase gene-transduced neural stem cells and ganciclovir
    Namba, Hiroki
    Li, Shaoyi
    Tokuyama, Tsutomu
    Yamamoto, Junkoh
    Yokota, Naoki
    JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 379 - 379
  • [26] Limited efficacy of gene transfer in herpes simplex virus-thymidine kinase/ganciclovir gene therapy for brain tumors
    Hadaczek, P
    Mirek, H
    Berger, MS
    Bankiewicz, K
    JOURNAL OF NEUROSURGERY, 2005, 102 (02) : 328 - 335
  • [27] Vesicular Stomatitis Virus G Glycoprotein and ATRA Enhanced Bystander Killing of Chemoresistant Leukemic Cells by Herpes Simplex Virus Thymidine Kinase/Ganciclovir
    Hu, Chenxi
    Chen, Zheng
    Zhao, Wenjun
    Wei, Lirong
    Zheng, Yanwen
    He, Chao
    Zeng, Yan
    Yin, Bin
    BIOMOLECULES & THERAPEUTICS, 2014, 22 (02) : 114 - 121
  • [28] In vivo enhancement of Herpes simplex virus thymidine kinase/ganciclovir cancer gene therapy with polyamine biosynthesis inhibition
    Wahlfors, T
    Hakkarainen, T
    Jänne, J
    Alhonen, L
    Wahlfors, J
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (11) : 2907 - 2910
  • [29] Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
    Maatta, Ann-Marie
    Samaranayake, Haritha
    Pikkarainen, Jere
    Wirth, Thomas
    Yla-Herttuala, Seppo
    CURRENT GENE THERAPY, 2009, 9 (05) : 356 - 367
  • [30] Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of hepatocellular carcinoma
    Wang, Jianfeng
    Shi, Yaoping
    Bai, Zhibin
    Li, Yonggang
    Qiu, Longhua
    Johnson, Guy
    Zhang, Feng
    Yang, Xiaoming
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2017, 33 (02) : 170 - 177